vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Finwise Bancorp (FINW). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $42.7M, roughly 2.0× Finwise Bancorp). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 6.4%, a 16.4% gap on every dollar of revenue. Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 47.0%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.
FDMT vs FINW — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $42.7M |
| Net Profit | $19.4M | $2.7M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | — |
| Net Margin | 22.8% | 6.4% |
| Revenue YoY | 8508900.0% | — |
| Net Profit YoY | 139.1% | — |
| EPS (diluted) | $0.43 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $42.7M | ||
| Q4 25 | $85.1M | $46.9M | ||
| Q3 25 | $90.0K | $36.7M | ||
| Q2 25 | $15.0K | $25.1M | ||
| Q1 25 | $14.0K | $22.1M | ||
| Q4 24 | $1.0K | $21.1M | ||
| Q3 24 | $3.0K | $20.8M | ||
| Q2 24 | $5.0K | $19.8M |
| Q1 26 | — | $2.7M | ||
| Q4 25 | $19.4M | $3.9M | ||
| Q3 25 | $-56.9M | $4.9M | ||
| Q2 25 | $-54.7M | $4.1M | ||
| Q1 25 | $-48.0M | $3.2M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | $-43.8M | $3.5M | ||
| Q2 24 | $-35.0M | $3.2M |
| Q1 26 | — | — | ||
| Q4 25 | 17.3% | 11.7% | ||
| Q3 25 | -67983.3% | 17.5% | ||
| Q2 25 | -396373.3% | 21.7% | ||
| Q1 25 | -383007.1% | 20.1% | ||
| Q4 24 | — | 17.5% | ||
| Q3 24 | -1704400.0% | 22.2% | ||
| Q2 24 | -849120.0% | 21.1% |
| Q1 26 | — | 6.4% | ||
| Q4 25 | 22.8% | 8.4% | ||
| Q3 25 | -63195.6% | 13.3% | ||
| Q2 25 | -364386.7% | 16.3% | ||
| Q1 25 | -342657.1% | 14.4% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | -1461433.3% | 16.6% | ||
| Q2 24 | -699060.0% | 16.1% |
| Q1 26 | — | $0.20 | ||
| Q4 25 | $0.43 | $0.27 | ||
| Q3 25 | $-1.01 | $0.34 | ||
| Q2 25 | $-0.98 | $0.29 | ||
| Q1 25 | $-0.86 | $0.23 | ||
| Q4 24 | — | $0.19 | ||
| Q3 24 | $-0.79 | $0.25 | ||
| Q2 24 | $-0.63 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $196.6M |
| Total Assets | $566.7M | $899.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $402.7M | $163.4M | ||
| Q3 25 | $305.1M | $105.6M | ||
| Q2 25 | $293.2M | $90.1M | ||
| Q1 25 | $321.4M | $120.3M | ||
| Q4 24 | $424.9M | $109.2M | ||
| Q3 24 | $501.9M | $85.8M | ||
| Q2 24 | $541.9M | $89.0M |
| Q1 26 | — | $196.6M | ||
| Q4 25 | $505.7M | $193.2M | ||
| Q3 25 | $369.0M | $187.8M | ||
| Q2 25 | $420.9M | $182.0M | ||
| Q1 25 | $469.7M | $177.4M | ||
| Q4 24 | $510.6M | $173.7M | ||
| Q3 24 | $552.9M | $170.4M | ||
| Q2 24 | $588.3M | $165.8M |
| Q1 26 | — | $899.4M | ||
| Q4 25 | $566.7M | $977.1M | ||
| Q3 25 | $424.0M | $899.9M | ||
| Q2 25 | $473.6M | $842.5M | ||
| Q1 25 | $515.7M | $804.1M | ||
| Q4 24 | $560.4M | $746.0M | ||
| Q3 24 | $604.0M | $683.0M | ||
| Q2 24 | $620.1M | $617.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | — |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 33.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $28.6M | $-28.4M | ||
| Q3 25 | $-46.5M | $3.5M | ||
| Q2 25 | $-43.4M | $-18.3M | ||
| Q1 25 | $-47.8M | $-21.6M | ||
| Q4 24 | $-134.6M | $-15.0M | ||
| Q3 24 | $-29.4M | $-9.8M | ||
| Q2 24 | $-30.2M | $-7.6M |
| Q1 26 | — | — | ||
| Q4 25 | $28.5M | $-28.6M | ||
| Q3 25 | $-46.6M | $3.4M | ||
| Q2 25 | $-43.4M | $-19.8M | ||
| Q1 25 | $-48.4M | $-23.3M | ||
| Q4 24 | $-138.4M | $-16.1M | ||
| Q3 24 | $-31.2M | $-13.4M | ||
| Q2 24 | $-30.6M | $-7.7M |
| Q1 26 | — | — | ||
| Q4 25 | 33.5% | -61.1% | ||
| Q3 25 | -51765.6% | 9.4% | ||
| Q2 25 | -289620.0% | -79.0% | ||
| Q1 25 | -345635.7% | -105.3% | ||
| Q4 24 | -13837100.0% | -76.0% | ||
| Q3 24 | -1038966.7% | -64.3% | ||
| Q2 24 | -611840.0% | -38.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 101.1% | 0.1% | ||
| Q2 25 | 440.0% | 5.8% | ||
| Q1 25 | 4507.1% | 7.4% | ||
| Q4 24 | 378600.0% | 5.1% | ||
| Q3 24 | 59266.7% | 17.2% | ||
| Q2 24 | 6980.0% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.47× | -7.26× | ||
| Q3 25 | — | 0.71× | ||
| Q2 25 | — | -4.48× | ||
| Q1 25 | — | -6.78× | ||
| Q4 24 | — | -5.37× | ||
| Q3 24 | — | -2.84× | ||
| Q2 24 | — | -2.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
FINW
| Net Interest Income | $28.1M | 66% |
| Noninterest Income | $14.6M | 34% |
